Page 90 - AN-2-4

Advanced Neurology Narcolepsy-multiple sclerosis coexistence

Formal analysis: Minkai Zhang, Linjie Yu https://doi.org/10.5604/17322693.1015529
Writing–original draft: Jinglong Hu 6. Ohayon MM, Priest RG, Zulley J, et al., 2002, Prevalence of
Writing–review & editing: Meijuan Zhang narcolepsy symptomatology and diagnosis in the European
general population. Neurology, 58: 1826–1833.
Ethics approval and consent to participate
https://doi.org/10.1212/wnl.58.12.1826
Ethics approval was not needed, and the patient had given 7. Nishino S, Kanbayashi T, 2005, Symptomatic narcolepsy,
consent prior to participation. cataplexy and hypersomnia, and their implications in the
Consent for publication hypothalamic hypocretin/orexin system. Sleep Med Rev,
9: 269–310.
Consent for publication was obtained from the patient. https://doi.org/10.1016/j.smrv.2005.03.004
Availability of data 8. de Lecea L, Kilduff TS, Peyron C, et al., 1998, The hypocretins:
Hypothalamus-specific peptides with neuroexcitatory
Data used in this case report is available from the activity. Proc Natl Acad Sci U S A, 95: 322–327.
corresponding author upon reasonable request.
https://doi.org/10.1073/pnas.95.1.322
References 9. Kanbayashi T, Shimohata T, Nakashima I, et al., 2009,
Symptomatic narcolepsy in patients with neuromyelitis
1. Trapp BD, Peterson J, Ransohoff RM, et al., 1998, Axonal optica and multiple sclerosis: New neurochemical and
transection in the lesions of multiple sclerosis. N Engl J Med, immunological implications. Arch Neurol, 66: 1563–1566.
338: 278–285.
https://doi.org/10.1001/archneurol.2009.264
https://doi.org/10.1056/nejm199801293380502
10. Kallweit U, Bassetti CLA, Oberholzer M, et al., 2018,
2. Barun B, 2013, Pathophysiological background and clinical Coexisting narcolepsy (with and without cataplexy) and
characteristics of sleep disorders in multiple sclerosis. Clin multiple sclerosis: Six new cases and a literature review.
Neurol Neurosurg, 115 Suppl 1: S82–S85. J Neurol, 265: 2071–2078.
https://doi.org/10.1016/j.clineuro.2013.09.028 https://doi.org/10.1007/s00415-018-8949-x
3. Golden EC, Lipford MC, 2018, Narcolepsy: Diagnosis and 11. Orthmann-Murphy JL, Calabresi PA, 2017, Therapeutic
management. Cleve Clin J Med, 85: 959–969. application of monoclonal antibodies in multiple sclerosis.
https://doi.org/10.3949/ccjm.85a.17086 Clin Pharmacol Ther, 101: 52–64.
4. Thompson AJ, Banwell BL, Barkhof F, et al., 2018, Diagnosis https://doi.org/10.1002/cpt.547
of multiple sclerosis: 2017 revisions of the McDonald 12. Leonavicius R, Adomaitiene V, 2014, Features of sleep
criteria. Lancet Neurol, 17: 162–173. disturbances in multiple sclerosis patients. Psychiatr Danub,
https://doi.org/10.1016/s1474-4422(17)30470-2 26: 249–255.
13. Scammell TE, Luo G, Borker P, et al., 2020, Treatment of
5. Zawilska JB, Woldan-Tambor A, Płocka A, et al., 2012,
Narcolepsy: Etiology, clinical features, diagnosis and narcolepsy with natalizumab. Sleep, 43: zsaa050.
treatment. Postepy Hig Med Dosw, 66: 771–786. https://doi.org/10.1093/sleep/zsaa050

Volume 2 Issue 4 (2023) 5 https://doi.org/10.36922/an.1913